BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND BCL2, Bcl-2, 596, ENSG00000171791
2411 results:

  • 1. LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
    Liu D; Wang W; Wu Y; Qiu Y; Zhang L
    Curr Cancer Drug Targets; 2024; 24(5):519-533. PubMed ID: 38804344
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Combination of Curcumin and
    Udompatanakorn C; Ratthawongjirakul P
    J Evid Based Integr Med; 2024; 29():2515690X241258369. PubMed ID: 38778767
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. N0 neck trial: Does intensification of follow-up (Ultrasound + Physical Examination) influence outcomes in early-stage oral cancer?
    Vaish R; Hawaldar R; Gupta S; Dandekar M; Shah S; Chaukar D; Pantvaidya G; Deshmukh A; Chaturvedi P; Pai P; Nair D; Nair S; Thakur M; Ghosh-Laskar S; Agarwal JP; D'Cruz AK
    Eur J Cancer; 2024 Jun; 204():114064. PubMed ID: 38705028
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anticancer potential of thiocolchicoside and lauric acid loaded chitosan nanogel against oral cancer cell lines: a comprehensive study.
    Mustafa A; Indiran MA; Ramalingam K; Perumal E; Shanmugham R; Karobari MI
    Sci Rep; 2024 Apr; 14(1):9270. PubMed ID: 38649421
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction.
    Thi Thanh Nguyen N; Yoon Lee S
    Biochem Pharmacol; 2024 Jun; 224():116221. PubMed ID: 38641308
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Plasmonic laser-responsive BioDissolve 3D-printed graphene@cisplatin-implant for prevention of post-surgical relapse of oral cancer.
    Anup N; Gadeval A; Ramdas Mule S; Gupta T; Kumar Tekade R
    Int J Pharm; 2024 May; 657():124123. PubMed ID: 38621618
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of Some Prognostic Biomarkers in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma.
    Alabiad MA; Said WMM; Adim AMA; Alorini M; Shalaby AM; Samy W; Elshorbagy S; Mandour D; Saber IM; Yahia AIO; Khairy DA
    Iran J Med Sci; 2024 Mar; 49(3):156-166. PubMed ID: 38584650
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells.
    Salama M; Ali A; Ibrahim FAR; Elabd S
    Med Oncol; 2024 Apr; 41(5):105. PubMed ID: 38573558
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Increasing Annual cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
    Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
    JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Causal relationship of genetically predicted gut microbiota with thyroid cancer: a bidirectional two-sample mendelian randomization study.
    Sun X; Chen S; Zhao S; Wang J; Cheng H
    Front Endocrinol (Lausanne); 2024; 15():1284472. PubMed ID: 38495789
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multifunctional curcumin mediated zinc oxide nanoparticle enhancing biofilm inhibition and targeting apoptotic specific pathway in oral squamous carcinoma cells.
    Tayyeb JZ; Priya M; Guru A; Kishore Kumar MS; Giri J; Garg A; Agrawal R; Mat KB; Arockiaraj J
    Mol Biol Rep; 2024 Mar; 51(1):423. PubMed ID: 38489102
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Carcinoma showing thymus-like elements (CASTLE) with amyloid deposition in the parotid gland.
    Hamada M; Miyama Y; Matsumura S; Shintani-Domoto Y; Urano M; Yasuda M
    Pathol Int; 2024 Apr; 74(4):227-233. PubMed ID: 38488752
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Thymoquinone potentiates anti-cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress.
    Fath MK; Nasiri K; Ghasemzadeh S; Nejati ST; Ghafari N; Masouleh SS; Dadgar E; Kazemi KS; Esfahaniani M
    Chem Biol Drug Des; 2024 Mar; 103(3):e14492. PubMed ID: 38485457
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
    Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
    J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hsa_circ_0001615 downregulation inhibits esophageal cancer development through miR-142-5p/β-catenin.
    Dai Y; Xu Q; Xia M; Chen C; Xiong X; Yang X; Wang W
    PeerJ; 2024; 12():e17089. PubMed ID: 38464761
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genoprotective role of pembrolizumab liposome in isolated lymphocytes from head and neck squamous cell carcinoma patients compared to those from healthy individuals
    Bobtina N; Alhawamdeh M; Habas K; Isreb M; Aburas B; Harris AT; Najafzadeh M; Anderson D
    Nanotoxicology; 2024 Feb; 18(1):55-68. PubMed ID: 38449434
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of key gene signatures and their characterization by expression correlation with drug sensitivity in smoking-associated oral squamous cell carcinoma.
    Gollapalli P; Alagundagi D; Ghate SD; Shetty VV; Shetty P; Patil P
    J Cancer Res Ther; 2023 Oct; 19(7):1743-1752. PubMed ID: 38376273
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic Significance of Tumor-Infiltrating Lymphocytes and High-Risk Human Papillomavirus in Ocular Sebaceous Carcinoma: A Comprehensive Analysis.
    Jeong SU; Song JS; Lee HJ; Sa HS; Cho KJ
    Mod Pathol; 2024 Apr; 37(4):100449. PubMed ID: 38369185
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
    Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
    Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation.
    Wang R; Gao Y; Wen S; Guo X
    BMC Med Genomics; 2024 Feb; 17(1):45. PubMed ID: 38302910
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 121.